Comparison of Clinicopathologic Characteristics and Survival Outcome Between Invasive Papillary Carcinoma and Invasive Ductal Carcinoma
- 16 November 2026
- journal article
- Published by Wiley in Surgical Practice
Abstract
Introduction: Invasive papillary carcinoma (IPC) of the breast is an exceptionally rare histological subtype. This study compared the clinicopathological characteristics, biomarker expression profiles and survival outcomes of IPC with those of invasive ductal carcinoma of no special type (IDC‐NST). Materials and Methods: The medical records of 6599 patients treated at the Breast Disease Research Center between December 1993 and December 2021 were retrospectively reviewed. Patients were categorized into IPC ( n = 27) and IDC ( n = 6572) groups. Tumour size, axillary lymph node status, pathologic stage, histologic grade, hormone receptor status (ER, PR), HER2 status, surgical management, adjuvant therapies and survival outcomes were analysed and compared. Survival distributions were evaluated using Kaplan–Meier curves and compared using the log‐rank test. Results: Patients with IPC were significantly older at presentation than those with IDC (mean age: 58.5 ± 14.0 vs. 49.0 ± 12.4 years, p = 0.02). Compared with IDC, IPC tumours demonstrated significantly less aggressive features, including a lower rate of axillary lymph node involvement (14.8% vs. 39.2%, p < 0.001) and a lower incidence of lymphovascular invasion (14.9% vs. 53.3%, p < 0.001). IPC tumours were predominantly low‐grade (Grade I: 70.3% vs. 20.5%, p < 0.001) and presented more frequently at Stage I (85.1% vs. 39.8%, p < 0.001). Adjuvant chemotherapy was administered significantly less often in the IPC group than in the IDC group (62.9% vs. 94.9%, p < 0.001). In stage‐specific analyses of Stage I disease, IPC exhibited favourable 5‐year disease‐free survival (81% vs. 69%, p = 0.008) and 5‐year overall survival (85% vs. 75%, p = 0.001) compared with Stage I IDC. Conclusion: IPC is a rare tumour type that presents unique clinicopathological characteristics and is associated with a higher rate of breast‐conserving surgery and a favourable prognosis than IDC.Funding Information
- Shiraz University of Medical Sciences (97‐17376)
This publication has 26 references indexed in Scilit:
- The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challengesHistopathology, 2025
- Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA‐19)Cancer Medicine, 2023
- Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of NorwayActa Oncologica, 2023
- Papillary neoplasm of the breast – A review and updateHuman Pathology Reports, 2021
- Clinicopathologic Characteristics and Prognosis of Invasive Papillary Carcinoma of the BreastJournal of Surgical Research, 2021
- The 2019 World Health Organization classification of tumours of the breastHistopathology, 2020
- Organ Sparing Surgery for Penile Cancer: A Systematic ReviewJournal of Urology, 2017
- Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based StudyScientific Reports, 2016
- Papillary and neuroendocrine breast lesions: the WHO stanceHistopathology, 2014
- Organ‐preserving surgery for penile cancer: description of techniques and surgical outcomesBJU International, 2012